Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 17 studies | 36% ± 13% | |
| peripheral blood | 17 studies | 41% ± 13% | |
| intestine | 13 studies | 30% ± 14% | |
| kidney | 8 studies | 32% ± 12% | |
| liver | 6 studies | 40% ± 21% | |
| lymph node | 6 studies | 44% ± 17% | |
| bone marrow | 5 studies | 31% ± 8% | |
| uterus | 5 studies | 43% ± 18% | |
| brain | 5 studies | 25% ± 6% | |
| pancreas | 4 studies | 53% ± 14% | |
| placenta | 4 studies | 47% ± 21% | |
| prostate | 4 studies | 41% ± 15% | |
| breast | 4 studies | 46% ± 11% | |
| ovary | 3 studies | 28% ± 12% | |
| eye | 3 studies | 30% ± 7% | |
| adrenal gland | 3 studies | 36% ± 13% | |
| esophagus | 3 studies | 43% ± 24% | |
| thymus | 3 studies | 56% ± 31% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5687.95 | 1445 / 1445 | 100% | 442.48 | 183 / 183 |
| ovary | 100% | 4568.26 | 180 / 180 | 100% | 479.46 | 430 / 430 |
| uterus | 100% | 5436.86 | 170 / 170 | 100% | 569.85 | 459 / 459 |
| skin | 100% | 7423.19 | 1809 / 1809 | 100% | 366.70 | 471 / 472 |
| intestine | 100% | 5022.34 | 966 / 966 | 99% | 529.36 | 524 / 527 |
| thymus | 100% | 4246.99 | 652 / 653 | 100% | 254.47 | 602 / 605 |
| stomach | 100% | 3916.58 | 359 / 359 | 99% | 476.59 | 284 / 286 |
| prostate | 100% | 4712.09 | 245 / 245 | 99% | 254.96 | 498 / 502 |
| bladder | 100% | 4748.90 | 21 / 21 | 99% | 544.70 | 499 / 504 |
| adrenal gland | 100% | 5127.99 | 258 / 258 | 99% | 217.03 | 227 / 230 |
| kidney | 100% | 4352.62 | 89 / 89 | 99% | 182.19 | 889 / 901 |
| breast | 100% | 5697.81 | 459 / 459 | 99% | 324.10 | 1102 / 1118 |
| lung | 100% | 5546.13 | 577 / 578 | 99% | 376.91 | 1138 / 1155 |
| pancreas | 99% | 2185.54 | 324 / 328 | 98% | 266.68 | 175 / 178 |
| liver | 100% | 2502.75 | 225 / 226 | 97% | 238.31 | 392 / 406 |
| brain | 93% | 1969.21 | 2468 / 2642 | 97% | 173.19 | 682 / 705 |
| adipose | 100% | 5340.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 244.85 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 634.20 | 29 / 29 |
| spleen | 100% | 6802.73 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 545.14 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 302.75 | 1 / 1 |
| blood vessel | 100% | 4708.18 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 3211.40 | 798 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 6724.65 | 921 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 2551.97 | 847 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000387 | Biological process | spliceosomal snRNP assembly |
| GO_0036261 | Biological process | 7-methylguanosine cap hypermethylation |
| GO_1903241 | Biological process | U2-type prespliceosome assembly |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0006479 | Biological process | protein methylation |
| GO_0008380 | Biological process | RNA splicing |
| GO_0046540 | Cellular component | U4/U6 x U5 tri-snRNP complex |
| GO_0005686 | Cellular component | U2 snRNP |
| GO_0005685 | Cellular component | U1 snRNP |
| GO_0005681 | Cellular component | spliceosomal complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0071007 | Cellular component | U2-type catalytic step 2 spliceosome |
| GO_0005697 | Cellular component | telomerase holoenzyme complex |
| GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
| GO_0005683 | Cellular component | U7 snRNP |
| GO_0034709 | Cellular component | methylosome |
| GO_0034719 | Cellular component | SMN-Sm protein complex |
| GO_0071204 | Cellular component | histone pre-mRNA 3'end processing complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005684 | Cellular component | U2-type spliceosomal complex |
| GO_0005682 | Cellular component | U5 snRNP |
| GO_0005687 | Cellular component | U4 snRNP |
| GO_0071004 | Cellular component | U2-type prespliceosome |
| GO_0071013 | Cellular component | catalytic step 2 spliceosome |
| GO_0030532 | Cellular component | small nuclear ribonucleoprotein complex |
| GO_0005689 | Cellular component | U12-type spliceosomal complex |
| GO_0005634 | Cellular component | nucleus |
| GO_1990447 | Molecular function | U2 snRNP binding |
| GO_0070990 | Molecular function | snRNP binding |
| GO_0071208 | Molecular function | histone pre-mRNA DCP binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0070034 | Molecular function | telomerase RNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_1990446 | Molecular function | U1 snRNP binding |
| Gene name | SNRPB |
| Protein name | Small nuclear ribonucleoprotein polypeptides B and B1 Small nuclear ribonucleoprotein-associated proteins B and B' (snRNP-B) (Sm protein B/B') (Sm-B/B') (SmB/B') Small nuclear ribonucleoprotein-associated protein |
| Synonyms | SNRPB1 COD hCG_2039421 |
| Description | FUNCTION: Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome . Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes . As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs . As part of the U7 snRNP it is involved in histone pre-mRNA 3'-end processing . . |
| Accessions | B4DVS0 ENST00000438552.6 [P14678-1] S4R3P3 Q66K91 ENST00000381342.7 [P14678-2] P14678 ENST00000474384.2 Q15182 Q9UIS4 |